HomeCompareEKTAF vs NOBL

EKTAF vs NOBL: Dividend Comparison 2026

EKTAF yields 4.14% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKTAF wins by $66.2K in total portfolio value
10 years
EKTAF
EKTAF
● Live price
4.14%
Share price
$6.20
Annual div
$0.26
5Y div CAGR
33.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.0K
Annual income
$24,064.33
Full EKTAF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — EKTAF vs NOBL

📍 EKTAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKTAFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKTAF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKTAF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKTAF
Annual income on $10K today (after 15% tax)
$352.23/yr
After 10yr DRIP, annual income (after tax)
$20,454.68/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, EKTAF beats the other by $20,245.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKTAF + NOBL for your $10,000?

EKTAF: 50%NOBL: 50%
100% NOBL50/50100% EKTAF
Portfolio after 10yr
$55.9K
Annual income
$12,155.25/yr
Blended yield
21.73%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKTAF buys
0
NOBL buys
0
No recent congressional trades found for EKTAF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKTAFNOBL
Forward yield4.14%2.14%
Annual dividend / share$0.26$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.2%0%
Portfolio after 10y$89.0K$22.8K
Annual income after 10y$24,064.33$246.19
Total dividends collected$61.5K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: EKTAF vs NOBL ($10,000, DRIP)

YearEKTAF PortfolioEKTAF Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$11,252$551.96$10,914$214.34+$338.00EKTAF
2$12,813$773.14$11,897$218.63+$916.00EKTAF
3$14,806$1,095.96$12,952$222.72+$1.9KEKTAF
4$17,418$1,576.51$14,086$226.62+$3.3KEKTAF
5$20,947$2,308.89$15,302$230.33+$5.6KEKTAF
6$25,869$3,456.43$16,607$233.85+$9.3KEKTAF
7$32,994$5,313.97$18,007$237.18+$15.0KEKTAF
8$43,741$8,437.06$19,508$240.35+$24.2KEKTAF
9$60,727$13,923.91$21,116$243.35+$39.6KEKTAF
10$89,042$24,064.33$22,841$246.19+$66.2KEKTAF

EKTAF vs NOBL: Complete Analysis 2026

EKTAFStock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Full EKTAF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this EKTAF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKTAF vs SCHDEKTAF vs JEPIEKTAF vs OEKTAF vs KOEKTAF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.